ArticleAmerican journal of respiratory and critical care medicine2023
Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study.
Abstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
5.8field-weighted citation impact, top 4% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 20 citations in OpenAlex.
- Defining and predicting disease progression in myeloproliferative neoplasms: a proposed biomarker-driven approach.Leukemia · 2026Review
- Progression of chronic thromboembolic pulmonary disease without pulmonary hypertension in a case withJournal of cardiology cases · 2026Article
- Review
- The pulmonary artery hypertension and cancer: PULAHYCA PILOT study. Initial prostanoid therapy in cancer patients with pulmonary hypertension: results from an observational study.Cardio-oncology (London, England) · 2026Article
- Exploring the Association Between Pulmonary Hypertension and Cancer: A Systematic Review and Meta-Analysis.Biomedicines · 2026Review
- Sotatercept for the Treatment of Myeloproliferative Neoplasm-Associated Group 5 Pulmonary Hypertension.JACC. CardioOncology · 2026Article
- Diagnostic and management dilemmas in pulmonary hypertension.European respiratory review : an official journal of the European Respiratory Society · 2026Review
- Prevalence, Clinical Features, and Treatment Response of Chronic Thromboembolic Pulmonary Hypertension in Patients With Myeloproliferative Neoplasm.Circulation reports · 2026Article
- Longitudinal prospective analysis of organ stiffness and cardiac function in patients with myelofibrosis treated with ruxolitinib type of study: Prospective single-center cohort study.Therapeutic advances in hematology · 2026Article
- Intrathoracic manifestations of hematologic malignancies: a narrative review.Annals of translational medicine · 2025Review
- Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications.Journal of clinical medicine · 2025Article
- Characterization and prognostic implication of pulmonary hypertension among patients with myeloproliferative neoplasms.Haematologica · 2025Article
- Intersecting Pathways: The Impact of Philadelphia-Negative Chronic Myeloproliferative Neoplasms on the Pathogenesis and Progression of Heart Failure with Preserved Ejection Fraction.Diagnostics (Basel, Switzerland) · 2025Article
- Rare but serious: pulmonary vascular disease around the world.JHLT open · 2025Review
- Beyond Thrombosis: Pulmonary Hypertension and Heart Failure in Patients With Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review.JACC. CardioOncology · 2025Review
- Relapse of Acute Myelogenous Leukemia With History of Myeloproliferative Neoplasm and Exacerbation of Pulmonary Hypertension.JACC. Case reports · 2025Article
- High pulmonary hypertension risk by echocardiogram shortens survival in polycythemia vera.Blood advances · 2025Article
- Pulmonary Hypertension in the Field of Hematological and Oncological Diseases.Respiration; international review of thoracic diseases · 2025Review
- Myeloproliferative Neoplasms and Cardiovascular Disease: A Review.Current treatment options in oncology · 2024Review
- Time Relationship between the Occurrence of a Thromboembolic Event and the Diagnosis of Hematological Malignancies.Cancers · 2024Article
Corrections and comments
- Commented on by
Authors and funding
14 authors at 3 institutions in 1 country.
David MontaniSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0002-9358-6922
Pierre ThoréAssistance Publique - Hôpitaux de Paris, Department of Respiratory Medicine, Histiocytosis National Referral Center, Hôpital Saint-Louis, Paris, France.ORCID 0000-0001-7378-2419
Xavier MignardSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0002-5458-7770
Xavier JaïsSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0002-4104-7994
Athénaïs BouclySchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0001-6246-5557
Mitja JevnikarSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0003-0727-6790
Andrei SeferianSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0003-1007-433X
Etienne-Marie JutantDepartment of Pneumology, University Hospital of Poitiers, Institut National de la Santé et de la Recherche Médicale Centre D'investigation Clinique 1402, University of Poitiers, Poitiers, France; and.ORCID 0000-0002-1374-1890
Vincent CottinCentre Hospitalier Universitaire de Lyon Hospices Civils de Lyon, Service de Pneumologie, Centre de Référence des Maladies Pulmonaires Rares, Groupement Hospitalier Est, Hôpital Louis Pradel, Bron, France.ORCID 0000-0002-5591-0955
Elie FadelInstitut National de la Santé et de la Recherche Médicale Unité Mixte de Recherche 999 Pulmonary Hypertension: Pathophysiology and Novel Therapies and.ORCID 0000-0002-9290-4589
Gérald SimonneauSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Laurent SavaleSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0002-6862-8975
Olivier SitbonSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0002-1942-1951
Marc HumbertSchool of Medicine, Université Paris-Saclay, Le Kremlin-Bicêtre, France.ORCID 0000-0003-0703-2892
Inserm · FRHospices Civils de Lyon · FRUniversité Paris Cité · FR
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Hypertension, PulmonaryMyeloproliferative DisordersPolycythemia VeraThrombocythemia, EssentialHumansRegistrieschronic thromboembolic pulmonary hypertensionessential thrombocythemiamyeloproliferative neoplasmspolycythemia verapulmonary hypertension
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.